» Articles » PMID: 23880760

Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid is Dependent on Interplay Between P53 and Krüppel-like Factor 5

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Jul 25
PMID 23880760
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia-inducible factor 1α (HIF-1α) and p53 are pivotal regulators of tumor growth. Lysophosphatidic acid (LPA) is a lipid mediator that functions as a mitogen by acting through LPA receptors. We have shown previously that LPA stimulates HIF-1α expression in colon cancer cells. To determine the mechanism of HIF-1α induction by LPA, we compared the effect of LPA on HIF-1α in several colon cancer cell lines. LPA transcriptionally induced HIF-1α in colon cancer cells. HIF-1α induction was observed in cells expressing WT p53, where LPA decreased p53 expression. However, LPA failed to induce HIF-1α when the p53 gene was mutated. A decrease in p53 expression was dependent on induction of p53-specific E3 ubiquitin ligase Mdm2 by LPA. Krüppel-like factor 5 (KLF5) is an effector of LPA-induced proliferation of colon cancer cells. Because HIF-1α was necessary for LPA-induced growth of colon cancer cells, we determined the relationship between KLF5 and HIF-1α by a loss-of-function approach. Silencing of KLF5 inhibited LPA-induced HIF-1α induction, suggesting that KLF5 is an upstream regulator of HIF-1α. KLF5 and p53 binding to the Hif1α promoter was assessed by ChIP assay. LPA increased the occupancy of the Hif1α promoter by KLF5, while decreasing p53 binding. Transfection of HCT116 cells with KLF5 or p53 attenuated the binding of the other transcription factor. These results identify KLF5 as a transactivator of HIF-1α and show that LPA regulates HIF-1α by dynamically modulating its interaction with KLF5 and p53.

Citing Articles

KLF5 and p53 comprise an incoherent feed-forward loop directing cell-fate decisions following stress.

Yang Y, Bhargava D, Chen X, Zhou T, Dursuk G, Jiang W Cell Death Dis. 2023; 14(5):299.

PMID: 37130837 PMC: 10154356. DOI: 10.1038/s41419-023-05731-1.


New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.

Zeng L, Zhu Y, Moreno C, Wan Y Semin Cancer Biol. 2023; 90:29-44.

PMID: 36806560 PMC: 10023514. DOI: 10.1016/j.semcancer.2023.02.003.


Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.

Gupta V, Kumar A Apoptosis. 2022; 27(5-6):382-400.

PMID: 35366141 DOI: 10.1007/s10495-022-01723-2.


Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?.

Duflot T, Tu L, Leuillier M, Messaoudi H, Groussard D, Feugray G Metabolites. 2021; 11(11).

PMID: 34822442 PMC: 8621392. DOI: 10.3390/metabo11110784.


miR-320-3p regulates the proliferation, migration and apoptosis of hypoxia-induced pulmonary arterial smooth muscle cells via KLF5 and HIF1α.

Ding D, Jiang H, He Y, Li X, Liu X Am J Transl Res. 2021; 13(4):2283-2295.

PMID: 34017389 PMC: 8129266.


References
1.
Lin S, Wang D, Iyer S, Ghaleb A, Shim H, Yang V . The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology. 2009; 136(5):1711-20. PMC: 2691721. DOI: 10.1053/j.gastro.2009.01.002. View

2.
Deng W, Shuyu E, Tsukahara R, Valentine W, Durgam G, Gududuru V . The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 2007; 132(5):1834-51. PMC: 3446791. DOI: 10.1053/j.gastro.2007.03.038. View

3.
Lin S, Lee S, Shim H, Chun J, Yun C . The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. Am J Physiol Gastrointest Liver Physiol. 2010; 299(5):G1128-38. PMC: 2993170. DOI: 10.1152/ajpgi.00321.2010. View

4.
Rodrigues N, Rowan A, Smith M, Kerr I, Bodmer W, Gannon J . p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990; 87(19):7555-9. PMC: 54786. DOI: 10.1073/pnas.87.19.7555. View

5.
Yu Z, Geyer R, Maki C . MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene. 2000; 19(51):5892-7. DOI: 10.1038/sj.onc.1203980. View